Determination of acetylcholine receptor antibody in myasthenia gravis: clinical usefulness and pathogenetic implications.
about
Acetylcholine receptor antibody as a diagnostic test for myasthenia gravis: results in 153 validated cases and 2967 diagnostic assays.Ryanodine receptor antibodies related to severity of thymoma associated myasthenia gravis.The CD45 77C/G allele is not associated with myasthenia gravis - a reassessment of the potential role of CD45 in autoimmunityAcetylcholine receptor-reactive T and B cells in myasthenia gravis and controls.Myasthenia gravis and Waldenström's macroglobulinemia: a case report and review of the literature.Recombinant expression of the AChR-alpha1 subunit for the detection of conformation-dependent epitopes in Myasthenia Gravis.Tissue-specific antibodies in myasthenia gravis.Patterns and severity of neuromuscular transmission failure in seronegative myasthenia gravisTransient neonatal myasthenia gravis.Therapeutic apheresis in neurology critical care.Myasthenia gravis: a long term follow-up study of Swedish patients with specific reference to thymic histology.Linkage between the frequency of muscular weakness and loci that regulate immune responsiveness in murine experimental myasthenia gravis.Muscle autoantibodies in myasthenia gravis: beyond diagnosis?Ocular myasthenia gravis: response to long-term immunosuppressive treatment.Immune complexes in myasthenia gravis.Patient-specific anti=acetylcholine receptor antibody patterns in myasthenia gravisAnti-acetylcholine receptor antibody titres in the sera of myasthenia patients treated with plasma exchange combined with immunosuppressive therapyAnti-acetylcholine receptor antibodies.Immune disease and HLA associations with myasthenia gravis.Passively transferred myasthenia gravis: protection of mouse endplates by Fab fragments from human myasthenic IgG.Radioimmunoassay of serum myoglobin in neuromuscular diseases.Circulating immune complexes in myasthenia gravis: a study in relation to thymectomy, clinical severity and thymus histology.Immunoadsorption versus plasma exchange versus combination for treatment of myasthenic deteriorationThe auto-antigen repertoire in myasthenia gravis.Myasthenia gravis, an autoimmune manifestation of lymphoma and lymphoproliferative disorders: case reports and review of literature.Differences in the interaction of acetylcholine receptor antibodies with receptor from normal, denervated and myasthenic human muscle.Tests for juvenile myasthenia gravis: comparative diagnostic yield and prediction of outcome.The CD5+ B cells and myasthenia gravis.Serological and clinical features of patients with myasthenia gravis in north Indian population.Myasthenia gravis with thymoma is not associated with an increased incidence of non-muscle autoimmune disorders.Thymectomy and anti-muscle autoantibodies in late-onset myasthenia gravis.Heart muscle antibodies in myasthenia gravis.Expression of OX40 (CD134) on CD4+ T-cells from patients with myasthenia gravis.Investigation for RAPSN and DOK-7 mutations in a cohort of seronegative myasthenia gravis patients.Does change in acetylcholine receptor antibody level correlate with clinical change in myasthenia gravis?Myasthenia gravis epidemiology in a national cohort; combining multiple disease registries.Both binding and blocking antibodies correlate with disease severity in myasthenia gravis.The Use of Human Mesenchymal Stem Cells as Therapeutic Agents for the Treatment of Immune-Related Diseases: A Systematic ReviewNeonatal Myasthenia Gravis and the Role of Agalactosyl IgG
P2860
Q33621733-AD9F4481-D93D-468D-B518-91F7E19F155CQ33732795-7D360F0A-A667-4747-BD63-16863181AAFBQ33743507-3E66DFE6-6EED-4000-848C-794005887A52Q34265395-A44BF758-E45C-4118-A140-A395F92A9570Q34394001-7E7FA1F2-409F-446A-8FEB-23A20F71C812Q34612779-9BCF2963-80D9-4E64-85FE-0CA2ABACEB50Q34860454-83725793-FE0D-4E93-A37F-2BA67CC1C326Q35487694-167D45AC-6C73-45B7-B14A-706E3F18CF83Q36054914-0D188E3A-4638-4257-9EA0-A0BFADDE6C89Q36215377-D7AF1E5D-DEBE-4D9E-A677-032C005FF853Q36226648-2A753514-CD28-4DEE-8E3A-6A707C3C7659Q36343935-28DBD023-2B7C-40F4-A895-22C4FF8B6177Q36420763-82DCF050-91A5-4709-BA41-6976A68BC626Q36902041-042A51B4-60C9-4E4E-949E-B8AC9EBF6736Q36993916-907B9477-32B8-44C4-926A-B5F103382E1AQ36997961-3932B366-BF92-45C4-A700-3EC777AF1E6DQ36998741-41B1C9D0-43CF-468F-B764-B5FC86BA1D0BQ37000298-8DB0837A-76F9-4F6B-93FE-33F19A006C39Q37000345-9960B95F-7D5E-4ECC-B1D5-B036068F6363Q37001311-E905E394-843F-4FCD-B38D-CB2544BD6D7BQ37005176-997FBB04-2719-4FDC-B97F-FF019782F73AQ37015305-93DB3744-B81D-4BF8-BA53-2BC1C191D113Q37027684-BB7B2B7E-C05A-4880-BF40-B98C0FFC3222Q37727984-64607003-E39A-4A85-B022-232AFBCB74B1Q37921751-140E26C7-D4FA-417D-8E93-D7E60FC8C4DCQ39260833-72321012-D0E3-499D-B3E1-E247954B1602Q40775110-04EB90E4-EDC7-4AC3-BBCA-8D13CBB84F68Q41401926-E8F20239-6140-4F52-83F4-04FC54CDAE68Q43144131-726D396C-6274-4D33-939C-93F156A26AFBQ43584781-381E76BF-BAAC-488E-B35B-A0C0D31BB425Q43849922-5F419B2C-0EB9-40C6-9EB1-C5A05176AB56Q46423588-EE733883-4500-458A-9B74-0136F993CBBFQ46860994-22098ED3-C78C-4DF9-9701-7E4C7C1EB5B6Q48060092-75AC3A9C-A190-456B-9A92-8999525553ACQ50851397-3747144F-B017-4F2B-AF04-562E62794CE2Q51240646-89D365B7-E4DD-437E-9921-3509EE9DEB03Q53510950-08A85F1C-7566-4D00-B804-DF19AD81E859Q57538743-BDC99EE8-BA62-4D6B-9047-898F397BCBBCQ58826908-0B55ABA0-3AD7-47B3-931E-BE3070016166
P2860
Determination of acetylcholine receptor antibody in myasthenia gravis: clinical usefulness and pathogenetic implications.
description
1978 nî lūn-bûn
@nan
1978年の論文
@ja
1978年学术文章
@wuu
1978年学术文章
@zh-cn
1978年学术文章
@zh-hans
1978年学术文章
@zh-my
1978年学术文章
@zh-sg
1978年學術文章
@yue
1978年學術文章
@zh
1978年學術文章
@zh-hant
name
Determination of acetylcholine ...... and pathogenetic implications.
@en
Determination of acetylcholine ...... and pathogenetic implications.
@nl
type
label
Determination of acetylcholine ...... and pathogenetic implications.
@en
Determination of acetylcholine ...... and pathogenetic implications.
@nl
prefLabel
Determination of acetylcholine ...... and pathogenetic implications.
@en
Determination of acetylcholine ...... and pathogenetic implications.
@nl
P2093
P2860
P921
P356
P1476
Determination of acetylcholine ...... and pathogenetic implications.
@en
P2093
Bergström K
Lefvert AK
Osterman PO
Pirskanen R
P2860
P304
P356
10.1136/JNNP.41.5.394
P407
P577
1978-05-01T00:00:00Z